View |
|
BR-619
|
Tetanus Toxoid Adsorbed
|
IMATET
|
40 IU/0.5 ML
|
SUSPENSION FOR INJECTION (IM)
|
VACCINE
|
AMSON VACCINES & PHARMA (PVT.) LTD.
|
Pakistan
|
Renewal
|
05 August 2022
|
24 August 2027
|
View |
|
BR-628
|
Antithymocyte Immunoglobulin (ATG) (Equine)
|
Thymogam
|
50 mg/ mL (250 mg/5 mL)
|
Solution for IV Infusion
|
-
|
Bharat Serums and Vaccines Ltd.
|
India
|
-
|
17 February 2021
|
08 February 2025
|
View |
|
BR-629
|
Purified Vero Cell Rabies Vaccine
|
Abhayrab
|
2.5 IU/0.5 mL
|
Freeze Dried Powder For Injection (I.M./I.D.)
|
Vaccine
|
Human Biologicals Institute (A Division of Indian Immunologicals Limited)
|
India
|
Automatic Renewal
|
22 December 2022
|
21 February 2028
|
View |
|
BR-630
|
Diphtheria-Tetanus Toxoids And Acellular Pertussis Vaccine, Adsorbed
|
Boostrix
|
Formulation: Each dose (0.5 mL) contains:
Diphtheria toxoid -2.5LF Tetanus toxoid-5.0 Lf Pertussis toxoid-8 mcg Filamentous hemagglutinin (FHA)-8 mcg Pertactin (PRN or 69 kDa OMP)-2.5 mcg
|
0.5 mL Suspension for Injection (IM) - 2PE (See reverse for Formulation)
|
-
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
-
|
19 February 2021
|
09 September 2025
|
View |
|
BR-632
|
Epoetin alfa (Recombinant Human Erythropoietin)
|
Epotin
|
4000 IU/ mL
|
Solution for Injection (IV/SC)
|
Other Antianemic Preparations
|
Gulf Pharmaceuticals Industries (Julphar)
|
UAE
|
Automatic Renewal
|
10 August 2021
|
19 August 2026
|
View |
|
BR-636
|
Human Normal Immunoglobulin (IGIV)
|
Gamma Iv
|
50 mg/mL (5 g/100 mL)
|
Solution for Injection (IV)
|
-
|
Bharat Serums and Vaccine Limited
|
India
|
-
|
17 February 2021
|
16 June 2025
|
View |
|
BR-637
|
Epoetin Alfa
|
Epokine
|
4000 IU/mL
|
Solution For Injection (IV/SC)
|
Anti-anaemic Preparations
|
HK inno.N Corporation
|
Korea
|
Automatic Renewal
|
07 January 2022
|
20 October 2026
|
View |
|
BR-638
|
Methoxy Polyethylene Glycol-Epoetin Beta
|
Mircera
|
50 mcg/0.3 mL
|
Solution for Injection (I.V./S.C.)
|
-
|
Roche Diagnostics GmbH
|
Germany
|
Automatic Renewal
|
18 September 2021
|
07 October 2026
|
View |
|
BR-645
|
Epoetin Alfa
|
Epogen
|
4000 IU/mL
|
Solution For Injection (IV/SC)
|
-
|
Harbin Pharmaceutical Group Bioengineering Co.,
Ltd.
|
China
|
-
|
08 October 2021
|
08 October 2024
|
View |
|
BR-647
|
Methoxy Polyethylene Glycol-Epoetin Beta
|
Mircera
|
100 mcg/0.3 mL
|
Solution for Injection (I.V./S.C.)
|
Erythropoiesis Stimulating Agent
|
Roche Diagnostics GmbH
|
Germany
|
Automatic Renewal
|
23 September 2021
|
15 September 2026
|
View |
|
BR-651
|
Human Normal Immunoglobulin
|
Ig Vena
|
50mg/mL
|
Solution For Infusion (Iv)
|
Immunoglobulin
|
Kedrion S.p.A
|
Italy
|
Renewal
|
02 November 2023
|
07 November 2028
|
View |
BR-653_PI_01.pdf
|
BR-653
|
Measles, Mumps, Rubella and Varicella Vaccine (Live,
Attenuated)
|
Priorix-Tetra
|
0.5 mL
|
Powder for Solution for Injection (S.C./1.M.)
|
-
|
GlaxoSmithKline Biologicals SA (GSK Biologicals)
|
Belgium
|
Monitored Release (Variation)
|
11 July 2022
|
11 July 2027
|
View |
|
BR-658
|
Inactivated Purified Rabies Vaccine (Vero-Cell)
|
Indirab
|
2.5 IU
|
Lyophilized Powder For Injection (Id/Im)
|
Vaccines
|
Bharat Biotech International Ltd.
|
India
|
Renewal
|
14 November 2023
|
20 November 2028
|
View |
|
BR-659
|
Diphtheria, Tetanus, Acellular Pertussis, Inactivated
Poliomyelitis and Haemophilus influenzae Type B
Conjugate Vaccine, Adsorbed
|
Infanrix-IPV+Hib
|
0.5 mL
|
Suspension For Injection (Deep I.M.), 2PE Free
|
-
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
-
|
26 February 2021
|
19 July 2025
|
View |
|
BR-664
|
Cholera Vaccine (inactivated, oral)
|
OraVacs
|
Formulation Each capsule contains: Inactivated Whole Cell (WC)-5.0 x 10^10 of Vibrio cholerae 01 Inaba, classical biotype (heat inactivated)
Recombinant cholera toxin B subunit (ICTB)--1 mg (produced in V. cholerae 01 Inaba, classical biotype or El Tor biotype)
|
Enteric-Coated Capsule
|
-
|
Shanghai United Cell Biotechnology Co., Ltd.
|
China
|
-
|
17 December 2021
|
26 November 2024
|
View |
|
BR-669
|
Purified Rabies Vaccine (Vero Cell)
|
Speeda
|
2.5 IU
|
Freeze -Dried Powder for Injection (IM/ID)
|
Vaccine
|
Liaoning Cheng Da Biotechnology Co., Ltd.
|
China
|
Renewal
|
28 December 2018
|
03 February 2029
|
View |
|
BR-670
|
Recombinant Hepatitis B Vaccine
|
Amvax-B
|
10 mcg/0.5 mL
|
Suspension For Injection (IM)
|
Vaccine
|
Amson Vaccines & Pharma (Pvt.) Ltd
|
Pakistan
|
Renewal
|
19 January 2024
|
10 February 2029
|
View |
|
BR-674
|
Live Attenuated Rotavirus Vaccine
|
Rotarix
|
NLT 106.0 CCID 50/1.5 mL
|
Oral Suspension
|
-
|
GlaxoSmithKline Biologicals S.A.
|
Belgium
|
Renewal
|
15 September 2022
|
13 August 2027
|
View |
|
BR-675
|
Recombinant Hepatitis B Vaccine
|
Amvax-B
|
20 mcg/mL
|
Suspension For Injection (IM)
|
Vaccine
|
Amson Vaccines & Pharma (Pvt.) Ltd
|
Pakistan
|
Renewal
|
29 January 2024
|
06 March 2029
|
View |
|
BR-676
|
Anti-Rabies Serum (Equine)
|
Equirab
|
200 IU/ mL (1,000 IU/ 5mL)
|
Solution for Injection (IM/SC)
|
-
|
Bharat Serums and Vaccines Limited
|
India
|
-
|
30 March 2021
|
06 March 2026
|